Characteristics | Training set | P-value | Validation set | P-value | ||
---|---|---|---|---|---|---|
Low-malignant group (n = 109) | High-malignant group (n = 199) | Low-malignant group (n = 47) | High-malignant group (n = 85) | |||
Size (mean ± SD, cm) | 3.01 ± 1.01 | 8.22 ± 3.99 | < 0.001 | 3.17 ± 1.01 | 8.46 ± 4.44 | < 0.001 |
Cystoid variation (%) |  |  | < 0.001 |  |  | < 0.001 |
 + | 31 (28.44%) | 154 (77.39%) | 15 (31.91%) | 67 (78.82%) | ||
 – | 78 (71.56%) | 45 (22.61%) | 32 (68.09%) | 18 (21.18%) | ||
meanValue | 66.07 (54.55, 88.27) * | 51.19 (41.45, 65.41) * | < 0.001 | 64.52 (53.34, 86.89) * | 51.39 (39.91, 64.50) * | < 0.001 |
Pre-score | −0.38 (−0.67, −0.05) * | 1.44 (0.65, 2.73) * | < 0.001 | −0.38 (−0.62, −0.01) * | 1.44 (0.58, 3.06) * | < 0.001 |